arrow
G

Ghazaleh Tabatabai

eberhard karls university
H指数:61
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression

DNA甲基化谱分析鉴定出聚集性原钙粘蛋白的长程表观遗传沉默是脑膜瘤进展的关键决定因素

2026-08-290
OAAI
Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation

松果体区乳头状肿瘤中的年龄相关表观基因组异质性:一项多中心YoungNOA研究

2026-08-280
OA
Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial

作者更正: 新诊断的星形细胞瘤中的IDH1-mutant疫苗: 多中心,单臂,开放标签,人类第一阶段NOA16试验的最终分析

2026-08-030
OAAI
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial

IDH1突变疫苗在新诊断星形细胞瘤中的应用:多中心、单臂、开放标签、首次人体1期NOA16试验的最终分析

2026-07-010
OAAI
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial

鞘内注射nivolumab治疗伴软脑膜疾病的转移性实体瘤: 多中心IT-PD1/NOA-26 1期试验的剂量递增部分

2026-06-040
OAAI
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial

不同评分者间对复发胶质母细胞瘤可切除性的一致性存在差异:前瞻性、随机DIRECTOR试验的补充事后分析

2026-05-100
PRE
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial

基于L-RNA适配体的CXCL12抑制联合放射治疗和贝伐珠单抗在 newly-diagnosed glioblastoma 中的研究:扩展I/II期GLORIA试验

2026-04-080
OA
TERT Expression Predicts Progression-Free Survival in Meningiomas Independent of TERT Promoter Mutation

TERT表达预测脑膜瘤的无进展生存期,且与TERT启动子突变无关

2026-04-010
PRE
End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische Arbeitsgemeinschaft

神经肿瘤患者临终关怀中的挑战:德国青年神经肿瘤学工作组调查

2026-01-010
PRE
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma

基于DNA甲基化建模的头颅脑膜瘤临床管理框架

2025-11-190
OA
Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology

评估儿科、青少年和年轻成人脑膜瘤中的分子工具,强调了神经肿瘤学中需要全生命周期精确性

2025-11-080
OAAI
Employing nanopore sequencing on FFPE-derived DNA for CNS tumor diagnostics

采用纳米孔测序技术对FFPE来源的DNA进行中枢神经系统肿瘤诊断

2025-11-060
OAAI
IDENTIFICATION OF BCL FAMILY MEMBERS AS MODULATORS OF REGORAFENIB EFFICACY IN EXPERIMENTAL GLIOMA

鉴定BCL家族成员作为regorafenib疗效的调节因子在实验性胶质瘤中的作用

2025-10-010
OAAI
END-OF-LIFE CHALLENGES IN NEURO-ONCOLOGICAL PATIENT CARE: A YOUNGNOA SURVEY

神经肿瘤患者临终关怀中的挑战:一项YOUNGNOA调查

2025-10-010
OAAI